Literature DB >> 25588404

Authors' response: Importance of defining loss of response before therapeutic drug monitoring.

C Steenholdt1, M A Ainsworth1.   

Abstract

Keywords:  IBD CLINICAL

Mesh：

Substances：

Year:  2015        PMID： 25588404     DOI： 10.1136/gutjnl-2014-309044

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.

Authors:  Casper Steenholdt; Jørn Brynskov; Ole Ø Thomsen; Lars K Munck; Jan Fallingborg; Lisbet A Christensen; Gitte Pedersen; Jens Kjeldsen; Bent A Jacobsen; Anne Sophie Oxholm; Jakob Kjellberg; Klaus Bendtzen; Mark A Ainsworth
Journal:  Dig Dis Sci       Date:  2015-02-12       Impact factor: 3.199

Review 2.  Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review.

Authors:  Silvia Marquez-Megias; Ricardo Nalda-Molina; Javier Sanz-Valero; Patricio Más-Serrano; Marcos Diaz-Gonzalez; Maria Remedios Candela-Boix; Amelia Ramon-Lopez
Journal:  Pharmaceutics       Date:  2022-05-07       Impact factor: 6.525

3.  Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease.

Authors:  Casper Steenholdt; Mehmet Coskun; Sine Buhl; Klaus Bendtzen; Mark A Ainsworth; Jørn Brynskov; Ole H Nielsen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.